These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16025086)

  • 1. Soluble cathepsin K: a novel marker for the prediction of nontraumatic fractures?
    Holzer G; Noske H; Lang T; Holzer L; Willinger U
    J Lab Clin Med; 2005 Jul; 146(1):13-7. PubMed ID: 16025086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble cathepsin-L: a marker of bone resorption and bone density?
    Lang TH; Willinger U; Holzer G
    J Lab Clin Med; 2004 Sep; 144(3):163-6. PubMed ID: 15454886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women.
    Prezelj J; Ostanek B; Logar DB; Marc J; Hawa G; Kocjan T
    Menopause; 2008; 15(2):369-73. PubMed ID: 17882010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
    Piatek S; Adolf D; Wex T; Halangk W; Klose S; Westphal S; Amthauer H; Winckler S
    Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study.
    Ross PD; Kress BC; Parson RE; Wasnich RD; Armour KA; Mizrahi IA
    Osteoporos Int; 2000; 11(1):76-82. PubMed ID: 10663362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
    Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women.
    Adolf D; Wex T; Jahn O; Riebau C; Halangk W; Klose S; Westphal S; Amthauer H; Winckler S; Piatek S
    Maturitas; 2012 Feb; 71(2):169-72. PubMed ID: 22197348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
    Tumminello FM; Flandina C; Crescimanno M; Leto G
    Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
    Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
    Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.
    Schilling AF; Mülhausen C; Lehmann W; Santer R; Schinke T; Rueger JM; Amling M
    Osteoporos Int; 2007 May; 18(5):659-69. PubMed ID: 17206399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.
    Muñoz-Torres M; Reyes-García R; Mezquita-Raya P; Fernández-García D; Alonso G; Luna Jde D; Ruiz-Requena ME; Escobar-Jiménez F
    Maturitas; 2009 Nov; 64(3):188-92. PubMed ID: 19819089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Cathepsin K Plasma Level may Reflect an Association of Osteopoenia/Osteoporosis with Coronary Atherosclerosis and Coronary Artery Calcification in Male Patients with Stable Angina.
    Barbarash OL; Lebedeva NB; Kokov AN; Novitskaya AA; Hryachkova ON; Voronkina AV; Raskina TA; Kashtalap VV; Kutikhin AG; Shibanova IA
    Heart Lung Circ; 2016 Jul; 25(7):691-7. PubMed ID: 26988144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy.
    Mikosch P; Kerschan-Schindl K; Woloszczuk W; Stettner H; Kudlacek S; Kresnik E; Gallowitsch HJ; Lind P; Pietschmann P
    Thyroid; 2008 Jan; 18(1):27-33. PubMed ID: 18302515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of cathepsin K decrease with age in both women and men.
    Kerschan-Schindl K; Hawa G; Kudlacek S; Woloszczuk W; Pietschmann P
    Exp Gerontol; 2005 Jun; 40(6):532-5. PubMed ID: 15935595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early, noninvasive diagnostic of osteoporosis in men].
    Lepiarz-Rusek W; Kokocińska D
    Przegl Lek; 2005; 62(7):641-9. PubMed ID: 16463693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study.
    Schett G; Kiechl S; Weger S; Pederiva A; Mayr A; Petrangeli M; Oberhollenzer F; Lorenzini R; Redlich K; Axmann R; Zwerina J; Willeit J
    Arch Intern Med; 2006 Dec 11-25; 166(22):2495-501. PubMed ID: 17159016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
    Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
    Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.